GLP-1 receptor agonists semaglutide and tirzepatide are associated with reduced risks of dementia, stroke, and mortality in adults with type 2 diabetes and obesity, new data show.

Postoperative penile hypoxia is one potential contributor, Pedersen and co-authors noted. The rationale for LI-SWT to treat ...

The Two Speeds of European Healthcare Finland is demonstrating a different approach to modern healthcare—one that prioritizes ...

USA: A new study published in the Journal of Diabetes and Its Complications suggests that tirzepatide, a novel dual ...

A new study reveals that rectal spacers during prostate cancer radiation therapy significantly reduce long-term erectile dysfunction rates, enhancing patient outcomes.

For adults with obesity or overweight, tirzepatide-linked improvements in cardiometabolic risk factors are associated with the degree of weight reduction, according to a study published online ...

ON THIS PAGEDigestive Problems'Ozempic Face'Oral Hygiene ChangesHair LossWomen's HealthSee more (11) Ozempic and other drugs in the GLP-1 receptor agonist family have rapidly become famous for ...

Sex experts and medical doctors weigh in on the different types of erectile dysfunction, how to identify them, and solutions for erectile dysfunction.

Erectile dysfunction in younger men often signals deeper health issues like stress or hormonal imbalance, not just performance. Learn about causes & comprehensive treatments.

But what is compounded tirzepatide? Compounded tirzepatide is a formulation of tirzepatide that’s been changed in some way from the FDA-approved versions of the drug.

What to know about reports that some men on weight loss drugs are experiencing erectile dysfunction (ED).

Tirzepatide and semaglutide, both medications for obesity treatment, demonstrate similar safety and efficacy but tirzepatide resulted in greater levels of weight loss among patients compared with ...